| 000 | 01359 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512113907.0 | ||
| 264 | 0 | _c19730419 | |
| 008 | 197304s 0 0 eng d | ||
| 022 | _a0003-9926 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSolomon, J | |
| 245 | 0 | 0 |
_aChemotherapy of lymphoma with mechlorethamine and vinblastine. _h[electronic resource] |
| 260 |
_bArchives of internal medicine _cMar 1973 |
||
| 300 |
_a407-17 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBlood Cell Count |
| 650 | 0 | 4 |
_aBlood Platelet Disorders _xchemically induced |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aEvaluation Studies as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 |
_aLymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMechlorethamine _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aVinblastine _xadverse effects |
| 700 | 1 | _aJacobs, E M | |
| 700 | 1 | _aBateman, J R | |
| 700 | 1 | _aLukes, R J | |
| 700 | 1 | _aWeiner, J M | |
| 700 | 1 | _aDonohue, D M | |
| 773 | 0 |
_tArchives of internal medicine _gvol. 131 _gno. 3 _gp. 407-17 |
|
| 999 |
_c4573486 _d4573486 |
||